丘脑底核深部脑刺激治疗帕金森病15年以上长期结局
OBJECTIVE: To evaluate the effects of deep brain stimulation of the subthalamic nucleus (STN-DBS) on motor complications in patients with Parkinson disease (PD) beyond 15 years after surgery.…
要点
- STN-DBS术后超过15年仍能显著改善运动并发症。
- 异动症时间和关期时间分别减少75%和58.7%。
- 多巴胺能药物剂量减少50.6%,生活质量持续改善。
核心结论
- STN-DBS在术后超过15年仍有效,显著改善运动并发症并稳定减少多巴胺能药物。
- 尽管帕金森病自然进展导致左旋多巴抵抗性运动和非运动症状恶化,接受STN-DBS的患者仍能维持生活质量改善。
研究设计与样本
- 比较术前、术后1年及术后超过15年的运动并发症、生活质量、日常生活活动、UPDRS运动评分、多巴胺能治疗、刺激参数及副作用。
主要发现
- 与基线相比,异动症时间减少75%(p < 0.001),关期时间减少58.7%(p < 0.001)。
- 多巴胺能药物减少50.6%(p < 0.001)。
- 帕金森病生活质量问卷总分改善13.8%(p = 0.005),情绪功能改善13.6%(p = 0.01),社会功能改善29.9%(p < 0.001)。
- 随访期间观察到少量且大多可管理的设备相关不良事件。
关键数值与推荐
- 本研究提供Class IV证据表明,对于帕金森病患者,STN-DBS在术后15年仍有效治疗运动并发症。
临床怎么用
- 对于符合条件的帕金森病患者,STN-DBS可作为长期改善运动并发症和减少多巴胺能药物的有效治疗选择。
- 长期随访中需关注设备相关不良事件,并进行管理。
局限性
- 回顾性研究设计,证据等级为Class IV。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effects of deep brain stimulation of the subthalamic nucleus (STN-DBS) on motor complications in patients with Parkinson disease (PD) beyond 15 years after surgery. METHODS: Data on motor complications, quality of life (QoL), activities of daily living, Unified Parkinson's Disease Rating Scale motor scores, dopaminergic treatment, stimulation measures, and side effects of STN-DBS were retrospectively retrieved and compared before surgery, at 1 year, and beyond 15 years after bilateral STN-DBS. RESULTS: Fifty-one patients with 17.06 ± 2.18 years STN-DBS follow-up were recruited. Compared to baseline, the time spent with dyskinesia and the time spent in the "off" state were reduced by 75% (p < 0.001) and by 58.7% (p < 0.001), respectively. Moreover, dopaminergic drugs were reduced by 50.6% (p < 0.001). Parkinson's Disease Quality of Life Questionnaire total score and the emotional function and social function domains improved 13.8% (p = 0.005), 13.6% (p = 0.01), and 29.9% (p < 0.001), respectively. Few and mostly manageable device-related adverse events were observed during the follow-up. CONCLUSIONS: STN-DBS is effective beyond 15 years from the intervention, notably with significant improvement in motor complications and stable reduction of dopaminergic drugs. Furthermore, despite the natural continuous progression of PD with worsening of levodopa-resistant motor and nonmotor symptoms over the years, patients undergoing STN-DBS could maintain an improvement in QoL. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that, for patients with PD, STN-DBS remains effective at treating motor complications 15 years after surgery.
引用
- Bove F, Mulas D, Cavallieri F, et al. Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease. Neurology. 2021. PMID: 34078713. doi:10.1212/WNL.0000000000012246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。